Inventiva announces the presentation of five scientific abstracts at the AASLD The Liver Meeting™ 2021
18 oct. 2021 16h00 HE | INVENTIVA
Four poster presentations add to the evidence of the beneficial effects of lanifibranor therapy on key components of NASH, following further sub-analyses of Inventiva’s NATIVE Phase IIb clinical trial...
Inventiva annonce la présentation de cinq abstracts scientifiques lors du The Liver Meeting™ 2021 organisé par l’AASLD
18 oct. 2021 16h00 HE | INVENTIVA
Quatre présentations par poster confirment les effets bénéfiques de lanifibranor sur des composants clés de la NASH faisant suite à des analyses supplémentaires réalisées sur les résultats de l'étude...
Global Organ Care System for Liver Market Predicted to Garner a Revenue of $42.7 Million at a CAGR of 9.3% during the Forecast Period, 2019-2026 COVID-19 Disaster - Exclusive Report by Research Dive
21 sept. 2021 09h35 HE | Research Dive
New York, USA, Sept. 21, 2021 (GLOBE NEWSWIRE) -- According to a recent report by Research Dive, the global organ care system for liver market is forecasted to reach $42.7 million by the end of...
Inventiva’s 2021 First-Half Financial Results Presentation
10 sept. 2021 09h00 HE | INVENTIVA
Daix (France), September 10, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment...
Présentation des résultats financiers du 1er semestre 2021 d’Inventiva
10 sept. 2021 09h00 HE | INVENTIVA
Daix (France), le 10 septembre 2021 – Inventiva (Euronext Paris et Nasdaq : IVA), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale...
Global Cancer Stem Cells Market to Surpass $1,898.3 Million, Growing with a CAGR of 11.8% from 2019 to 2026, Post-COVID-19 Disaster by Research Dive
17 août 2021 09h02 HE | Research Dive
New York, USA, Aug. 17, 2021 (GLOBE NEWSWIRE) -- A newest report on the global cancer stem cells market has been added by Research Dive to its repository. The report presents exhaustive insights on...
Global Cancer Stem Cells Market to Witness Exponential Growth Owing to the Rising Efficiency of Stem Cell Therapy – Informative Report [180 Pages] by Research Dive
02 août 2021 09h00 HE | Research Dive
New York, USA, Aug. 02, 2021 (GLOBE NEWSWIRE) -- A recently published report by Research Dive states that the global cancer stem cells market is expected to witness a rise in revenue from $786.3...
Global Liver Institute Offering Multilingual Materials and Grants for International NASH Day on June 10
04 mars 2021 09h24 HE | Global Liver Institute
Washington, DC, March 04, 2021 (GLOBE NEWSWIRE) -- Global Liver Institute (GLI) is pleased to announce that the 2021 International NASH Day (#NASHday) will be held on June 10, 2021, with the theme,...
Surrozen Logo FINAL Large-1.png
Surrozen Awarded NIH Grant to Support Development of SZN-043, a Liver-Specific Regenerative Antibody, for the Treatment of Severe Alcoholic Hepatitis
15 oct. 2020 07h00 HE | Surrozen, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, has been awarded an NIH grant to...
89bio Announces Positive Topline Results from its Phase 1b/2a Trial of BIO89-100 in NASH
14 sept. 2020 07h01 HE | 89bio, Inc.
All dose groups achieved statistically significant reductions in liver fat, with relative reductions of up to 60% versus baseline and up to 70% versus placebo     Favorable safety and...